Gene · 57721
Papers4,298
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 4,298
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| METTL14-mediated m6A modification regulates endometrial receptivity by inhibiting SLC39A14. | J Reprod Immunol | 2025 | 39946761 | PubTator, text mining | PubMed |
| mRNA Transcript Variants Expressed in Mammalian Cells. | Int J Mol Sci | 2025 | 39940824 | PubTator, text mining | PubMed |
| Exploring m6A modifications in gastric cancer: from molecular mechanisms to clinical applications. | Eur J Med Res | 2025 | 39940056 | PubTator, text mining | PubMed |
| METTL14-mediated m6A modification of ZFP14 inhibits clear cell renal cell carcinoma progression via promoting STAT3 ubiquitination. | Clin Transl Med | 2025 | 39936533 | PubTator, text mining | PubMed |
| N6-Methyladenosine-Modified circSMAD4 Prevents Lumbar Instability Induced Cartilage Endplate Ossification. | Adv Sci (Weinh) | 2025 | 39936497 | PubTator, text mining | PubMed |
| METTL14-mediated m6A modification of LINC00340 exerts oncogenic role in retinoblastoma by regulating Notch signaling pathway. | Int Ophthalmol | 2025 | 39934516 | PubTator, text mining | PubMed |
| METTL14 modulates the progression and ferroptosis of colitis by regulating the stability of m6A-modified GPX4. | Eur J Med Res | 2025 | 39920858 | PubTator, text mining | PubMed |
| METTL14-mediated m6A modification of DDIT4 promotes its mRNA stability in aging-related idiopathic pulmonary fibrosis. | Epigenetics | 2025 | 39916577 | PubTator, text mining | PubMed |
| AQP3 Influences Unexplained Recurrent Abortion by Regulating Trophoblast Cell Migration and Invasion via the METTL14/IGF2BP1/AQP3/PI3K/AKT Pathway. | J Cell Mol Med | 2025 | 39878312 | PubTator, text mining | PubMed |
| METTL14-mediated depression of NEIL1 aggravates oxidative damage and mitochondrial dysfunction of lens epithelial cells through regulating KEAP1/NRF2 pathways. | Cell Signal | 2025 | 39855533 | PubTator, text mining | PubMed |
| Downregulation of N6-methyladenosine (m6A) methylation of Sema4D mRNA contributes to Treg dysfunction and allograft rejection. | Am J Transplant | 2025 | 39848338 | PubTator, text mining | PubMed |
| Helicobacter pylori reduces METTL14-mediated VAMP3 m6A modification and promotes the development of gastric cancer by regulating LC3C-mediated c-Met recycling. | Cell Death Discov | 2025 | 39827141 | PubTator, text mining | PubMed |
| Fine-tuning of gene expression through the Mettl3-Mettl14-Dnmt1 axis controls ESC differentiation. | Cell | 2025 | 39826545 | PubTator, text mining | PubMed |
| Cardiomyocyte-specific long noncoding RNA Trdn-as induces mitochondrial calcium overload by promoting the m6A modification of calsequestrin 2 in diabetic cardiomyopathy. | Front Med | 2025 | 39821729 | PubTator, text mining | PubMed |
| Divergent roles of m6A in orchestrating brown and white adipocyte transcriptomes and systemic metabolism. | Nat Commun | 2025 | 39788955 | PubTator, text mining | PubMed |
| Vitamin D receptor regulates methyltransferase like 14 to mitigate colitis-associated colorectal cancer. | J Genet Genomics | 2025 | 39778713 | PubTator, text mining | PubMed |
| Mettl14 and Mettl3 Work Cooperatively to Regulate Retinal Development. | Cell Biochem Funct | 2025 | 39739431 | PubTator, text mining | PubMed |
| Exosome-Shuttled METTL14 From AML-Derived Mesenchymal Stem Cells Promotes the Proliferation and Radioresistance in AML Cells by Stabilizing ROCK1 Expression via an m6A-IGF2BP3-Dependent Mechanism. | Drug Dev Res | 2025 | 39690960 | PubTator, text mining | PubMed |
| Exosomal miR-130a-3p confers cisplatin resistance in esophageal cancer by regulating ferroptosis via the suppression of METTL14-mediated m6A RNA methylation of FSP1. | Int Immunopharmacol | 2025 | 39689599 | PubTator, text mining | PubMed |
| Role of m6A methyltransferase METTL3 in keratoconus pathogenesis. | Exp Eye Res | 2025 | 39681235 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57721/papers?page=20